Ravi R - Search Results

1

Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy.

Bedi A, Chang X, Noonan K, Pham V, Bedi R, Fertig EJ, Considine M, Califano JA, Borrello I, Chung CH, Sidransky D, Ravi R. Bedi A, et al. Among authors: ravi r. Mol Cancer Ther. 2012 Nov;11(11):2429-39. doi: 10.1158/1535-7163.MCT-12-0101-T. Epub 2012 Aug 27. Mol Cancer Ther. 2012. PMID: 22927667 Free PMC article.

2

Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).

Ravi R, Bedi A. Ravi R, et al. Cancer Res. 2002 Mar 15;62(6):1583-7. Cancer Res. 2002. PMID: 11912124

3

Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.

Ravi R, Bedi A. Ravi R, et al. Cancer Res. 2002 Aug 1;62(15):4180-5. Cancer Res. 2002. PMID: 12154014

4

The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors.

Izumchenko E, Chang X, Michailidi C, Kagohara L, Ravi R, Paz K, Brait M, Hoque MO, Ling S, Bedi A, Sidransky D. Izumchenko E, et al. Among authors: ravi r. Cancer Res. 2014 Jul 15;74(14):3995-4005. doi: 10.1158/0008-5472.CAN-14-0110. Epub 2014 May 15. Cancer Res. 2014. PMID: 24830724 Free PMC article.

5

SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.

Ozawa H, Ranaweera RS, Izumchenko E, Makarev E, Zhavoronkov A, Fertig EJ, Howard JD, Markovic A, Bedi A, Ravi R, Perez J, Le QT, Kong CS, Jordan RC, Wang H, Kang H, Quon H, Sidransky D, Chung CH. Ozawa H, et al. Among authors: ravi r. Clin Cancer Res. 2017 Sep 1;23(17):5162-5175. doi: 10.1158/1078-0432.CCR-16-1686. Epub 2017 May 18. Clin Cancer Res. 2017. PMID: 28522603 Free PMC article.

6

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.

Ravi R, Noonan KA, Pham V, Bedi R, Zhavoronkov A, Ozerov IV, Makarev E, V Artemov A, Wysocki PT, Mehra R, Nimmagadda S, Marchionni L, Sidransky D, Borrello IM, Izumchenko E, Bedi A. Ravi R, et al. Nat Commun. 2018 Feb 21;9(1):741. doi: 10.1038/s41467-017-02696-6. Nat Commun. 2018. PMID: 29467463 Free PMC article.

7

Potential methods to circumvent blocks in apoptosis in lymphomas.

Ravi R, Bedi A. Ravi R, et al. Curr Opin Oncol. 2002 Sep;14(5):490-503. doi: 10.1097/00001622-200209000-00004. Curr Opin Oncol. 2002. PMID: 12192267 Review.

8

NF-kappaB in cancer--a friend turned foe.

Ravi R, Bedi A. Ravi R, et al. Drug Resist Updat. 2004 Feb;7(1):53-67. doi: 10.1016/j.drup.2004.01.003. Drug Resist Updat. 2004. PMID: 15072771 Review.

9

Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.

Ravi R, Jain AJ, Schulick RD, Pham V, Prouser TS, Allen H, Mayer EG, Yu H, Pardoll DM, Ashkenazi A, Bedi A. Ravi R, et al. Cancer Res. 2004 Dec 15;64(24):9105-14. doi: 10.1158/0008-5472.CAN-04-2488. Cancer Res. 2004. PMID: 15604280

10

Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling.

Ravi R, Fuchs EJ, Jain A, Pham V, Yoshimura K, Prouser T, Jalla S, Zhou X, Garrett-Mayer E, Kaufmann SH, Schulick RD, Pardoll DM, Bedi A. Ravi R, et al. Cancer Res. 2006 Feb 1;66(3):1730-9. doi: 10.1158/0008-5472.CAN-05-3377. Cancer Res. 2006. PMID: 16452233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters